Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp. Warrant

0.0900
+0.020028.57%
Volume:501.00
Turnover:45.11
Market Cap:- -
PE:- -
High:0.0900
Open:0.0900
Low:0.0900
Close:0.0700
Loading ...
Mar 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 13, 2023

Correspondence

Form CORRESP - Correspondence
Feb 23, 2023

Major Issues Report

Form 8-K - Current report
Feb 15, 2023

Major Issues Report

Form 8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 10, 2023

Major Issues Report

Form 8-K - Current report
Jan 24, 2023

Major Issues Report

Form 8-K - Current report
Jan 23, 2023

Major Issues Report

Form 8-K - Current report
Jan 18, 2023

Major Issues Report

Form 8-K - Current report
Jan 10, 2023

Major Issues Report

Form 8-K - Current report
Dec 14, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 08, 2022

Major Issues Report

Form 8-K - Current report
Jun 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 15, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Jun 14, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 26, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals